CARDINAL HEALTH INC
For the period ended Sep 30, 2026. Filed Nov 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 5, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unregistered Sales of Equity Securities and Use of Proceeds
Issuer Purchases of Equity Securities
| Period | Total Numberof SharesPurchased (1,2) | Average Price Paid per Share(2) | Total Number of SharesPurchasedas Part of Publicly Announced Programs (2,3) | ApproximateDollar Value ofShares That MayYet be PurchasedUnder the Program (3)(in millions) |
|---|---|---|---|---|
| July 2026 | 16 | $231.96 | — | $1,393 |
| Aug 2026 | 1,708,245 | 234.16 | 1,708,234 | 5,993 |
| Sept 2026 | 450,424 | 222.05 | 450,348 | 5,893 |
| Total | 2,158,685 | $231.63 | 2,158,582 | $5,893 |
(1)Reflects 16, 11, and 76 common shares purchased in July, August, and September 2026, respectively, through a rabbi trust as investments of participants in our Deferred Compensation Plan.
(2)On August 12, 2026, we entered into an ASR program to purchase common shares for an aggregate purchase price of $500 million and received an initial delivery of 1.7 million common shares using a reference price of $234.16. The ASR program concluded on September 18, 2026 at a volume weighted average price per common share of $231.63 resulting in a final delivery of 0.5 million common shares. See Note 10 of the "Notes to Condensed Consolidated Financial Statements" for additional information.
(3)On June 7, 2023, our Board of Directors approved a $3.5 billion share repurchase program, which will expire on December 31, 2027. On August 4, 2026, our Board of Directors approved a new $5.0 billion share repurchase program. As of September 30, 2026, we had $5.9 billion authorized for share repurchases remaining under these programs.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.